RxDoctor Payments Data

Sharon Frey

Infectious Disease · Saint Louis, MONPI 1356359228

Payments from drug & device makers

What this record shows

This record is dominated by education: $189 of the $213 with a category attached, or 88.7%. 3 manufacturers reported payments, led by Astellas Pharma US Inc at 46.5% of the total. That places this record below the midpoint for infectious disease clinicians in MO, where the typical reported total is $219.

$213in general payments, 2019–2025

Across 3 payments — averaging $71.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$99
  • Seqirus USA Inc$90
  • Bavarian Nordic A/s$24
$702,083in research payments, 2019–2025

Across 39 payments — averaging $18,002 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$606K
  • Bavarian Nordic A/s$91K
  • Takeda Pharmaceuticals U.S.A., Inc.$5K

What the payments were for

  • Food & beverage$2411%
  • Education$18989%

General payments by program year

19
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$213 in reported general payments places this provider in the 45th percentile of 177 infectious disease providers in Missouri.

See all infectious disease providers in Missouri

Other infectious disease in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →